Stevens-Johnson syndrome during nivolumab treatment of NSCLC.

about

Stevens-Johnson syndrome during nivolumab treatment of NSCLC.

Item

http://www.wikidata.org/entity/Q50089439

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Stevens-Johnson syndrome during nivolumab treatment of NSCLC.

@en

Stevens-Johnson syndrome during nivolumab treatment of NSCLC.

@nl

type

Item

label

Stevens-Johnson syndrome during nivolumab treatment of NSCLC.

@en

Stevens-Johnson syndrome during nivolumab treatment of NSCLC.

@nl

prefLabel

Stevens-Johnson syndrome during nivolumab treatment of NSCLC.

@en

Stevens-Johnson syndrome during nivolumab treatment of NSCLC.

@nl

P1476

Stevens-Johnson syndrome during nivolumab treatment of NSCLC.

@en

P2093

C Baldessari

http://www.w3.org/2001/XMLSchema#string

C Tomasello

http://www.w3.org/2001/XMLSchema#string

F Barbieri

http://www.w3.org/2001/XMLSchema#string

F Bertolini

http://www.w3.org/2001/XMLSchema#string

M Pifferi

http://www.w3.org/2001/XMLSchema#string

M Salati

http://www.w3.org/2001/XMLSchema#string

P2860

U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.

Activity and safety of radiotherapy with anti-PD-1 drug therapy in patients with metastatic melanoma.

Cytotoxic Cutaneous Adverse Drug Reactions during Anti-PD-1 Therapy.

Aprepitant for refractory nivolumab-induced pruritus.

Pembrolizumab-induced Stevens-Johnson syndrome in non-melanoma patients.

P304

283-284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDX640

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Cascinu

P577

2017-10-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29045532

http://www.w3.org/2001/XMLSchema#string